See All News >
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever
Pfizer (PFE) CEO on the Prowl for New Acquisitions
Pfizer (PFE) Pulls Plug on OTC Lipitor After Trial Failure
Allergan (AGN) Could Set its Sights on Another Transformative M&A Deal With Biogen (BIIB), Amgen (AMGN) or AbbVie (ABBV)
Takeover Target or Potential Buyer? Analysts Speculate on Biogen (BIIB)’s Future After Big Stock Drop
Biogen (BIIB) Chairman Reassures Investors With $3 Million Stock Buy
PDL BioPharma (PDLI) to Infuse Up to $200 Million Into Troubled Ariad (ARIA)
Merck & Co. (MRK) Snaps up Israel Oncology Firm cCam Biotherapeutics for $605 Million
Sanofi (SNY)'s Lixilan Hits Phase III Goal
Deerfield Management Launches $550 Million Biotech Fund
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal
Analysts Wait With Bated Breath for Gilead (GILD) Q2 Results, Possible Acquisition News
Allergan (AGN) Considers Breaking Up Into Two Businesses Months After Actavis (ACT) Merger
Progenics Pharmaceuticals, Inc. (PGNX) Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma And Paraganglioma
FibroGen, Inc. (FGEN) Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy
Mallinckrodt (MNK) Divests Contrast Media Biz to Guerbet (GBT) For $270 Million
Report Shows Gilead (GILD) Creates $3.5 Million per Employee
When Her Daughter Was Diagnosed With A Rare Disease, This Accountant Started A Biotech
See All News >
//-->